跳过至主要内容
翻译进行中 — 您的语言版本正在准备中，目前内容以英语显示。
返回讨论

Meet the under-35s shaping the future of biotech

Healthcare
全球
开始于 September 12, 2026

Every year, MIT Technology Review puts together a list of some of the brightest and best young minds working across science and technology. Our 35 Innovators Under 35 are the ones to watch—people whose research and technical work stands to shape the future of their fields. This year, the list includes nine people who are…

来源文章

添加陈述 分析 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
10 条陈述待投票 • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (10+ recommended) 10/10
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM 发布者 admin • Sep 12, 2026
Young biotech innovators should prioritize disease treatments that serve wealthy markets over rare diseases affecting poor populations.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 admin • Sep 12, 2026
Under-35s in biotech may prioritize profit over public health in their innovations.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 admin • Sep 12, 2026
The achievements of young innovators in biotech should be widely celebrated to encourage further innovation.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 admin • Sep 12, 2026
Public funding for biotech should be allocated based on project promise, not on lists of celebrated names or ages.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 admin • Sep 12, 2026
Breakthrough biotech discoveries should be evaluated by their scientific merit and potential impact, not the age or background of the researcher.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 admin • Sep 12, 2026
Biotech education programs should heavily feature the work of young innovators to inspire future generations.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 admin • Sep 12, 2026
Public support for biotech research should include initiatives led by under-35s.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 admin • Sep 12, 2026
Regulatory agencies should streamline approval pathways for therapies developed by younger researchers to accelerate time-to-patient.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 admin • Sep 12, 2026
The contributions of under-35s in biotech will likely lead to significant ethical dilemmas.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results
CLAIM 发布者 admin • Sep 12, 2026
Biotech innovation leadership should reflect the demographic diversity of the populations whose health outcomes depend on new discoveries.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
💬 查看讨论
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us